PubRank

Annemieke de Vries

Author PubWeight™ 31.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. Cancer Res 2009 1.82
2 Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer. Oncogene 2004 1.61
3 Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389. Mol Cell Biol 2004 1.44
4 Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development. Cancer Res 2005 1.26
5 Mouse models for the p53 R72P polymorphism mimic human phenotypes. Cancer Res 2010 1.10
6 In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma. Blood 2007 1.04
7 Dominant-negative but not gain-of-function effects of a p53.R270H mutation in mouse epithelium tissue after DNA damage. Cancer Res 2007 1.01
8 The absence of Ser389 phosphorylation in p53 affects the basal gene expression level of many p53-dependent genes and alters the biphasic response to UV exposure in mouse embryonic fibroblasts. Mol Cell Biol 2008 0.98
9 Discovery of novel serum biomarkers for prenatal Down syndrome screening by integrative data mining. PLoS One 2009 0.94
10 A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum. Int J Mol Sci 2012 0.92
11 Gene expression profiling in a mouse model identifies fetal liver- and placenta-derived potential biomarkers for Down Syndrome screening. PLoS One 2011 0.91
12 Mutation at p53 serine 389 does not rescue the embryonic lethality in mdm2 or mdm4 null mice. Oncogene 2004 0.89
13 Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas. Cancer Res 2005 0.89
14 lacZ mouse embryonic fibroblasts detect both clastogens and mutagens. Mutat Res 2009 0.89
15 Nucleotide excision repair- and p53-deficient mouse models in cancer research. Mutat Res 2005 0.88
16 Delayed expression of apoptotic and cell-cycle control genes in carcinogen-exposed bladders of mice lacking p53.S389 phosphorylation. Carcinogenesis 2007 0.86
17 Serious complications in gene-expression studies with stress perturbation: An example of UV-exposed p53-mutant mouse embryonic fibroblasts. Transcription 2010 0.84
18 RNA isolation for transcriptomics of human and mouse small skin biopsies. BMC Res Notes 2011 0.84
19 Identification of interleukin-1 beta, but no other inflammatory proteins, as an early onset pre-eclampsia biomarker in first trimester serum by bead-based multiplexed immunoassays. Prenat Diagn 2013 0.83
20 p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice. Cancer Res 2004 0.83
21 Integrative data mining to identify novel candidate serum biomarkers for pre-eclampsia screening. Prenat Diagn 2011 0.82
22 Combined oral benzo[a]pyrene and inhalatory ozone exposure have no effect on lung tumor development in DNA repair-deficient Xpa mice. Carcinogenesis 2003 0.81
23 Quantitative performance of antibody array technology in a prenatal screening setting. Clin Chem Lab Med 2011 0.81
24 Overlapping gene expression profiles of model compounds provide opportunities for immunotoxicity screening. Toxicol Appl Pharmacol 2007 0.81
25 Gene expression profiling of Bis(tri-n-butyltin)oxide (TBTO)-induced immunotoxicity in mice and rats. J Immunotoxicol 2006 0.81
26 Ozone induces clear cellular and molecular responses in the mouse lung independently of the transcription-coupled repair status. J Appl Physiol (1985) 2006 0.80
27 Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models. Carcinogenesis 2009 0.79
28 Identification of breast cancer biomarkers in transgenic mouse models: A proteomics approach. Proteomics Clin Appl 2010 0.79
29 2-AAF-induced tumor development in nucleotide excision repair-deficient mice is associated with a defect in global genome repair but not with transcription coupled repair. DNA Repair (Amst) 2005 0.79
30 Lasting effects on body weight and mammary gland gene expression in female mice upon early life exposure to n-3 but not n-6 high-fat diets. PLoS One 2013 0.78
31 Down syndrome screening: imagining the screening test of the future. Expert Rev Mol Diagn 2010 0.77
32 DNA-repair-deficient Rad54/Rad54B mice are more sensitive to clastogens than wild-type mice. Toxicol Lett 2008 0.76
33 Detecting genotoxic effects of potential clastogens: an in vivo study using the transgenic lacZ plasmid and the MutaMouse model. Mutat Res 2008 0.76
34 DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance? Carcinogenesis 2009 0.76
35 Biomarker discovery using a comparative omics approach in a mouse model developing heterogeneous mammary cancer subtypes. Proteomics 2012 0.75